SEC Form 4 · accession 0001209191-17-027736
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald D. Cagle
Director
Period of report
Apr 19, 2017
Accepted (ET)
Apr 20, 2017 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 19, 2017 | P | 1,000 | $41.60 | A | 10,900 | D | |
| Common Stock | Apr 19, 2017 | P | 1,000 | $41.80 | A | 11,900 | D |
Table II — derivative securities
No Table II lines on this filing.